| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C S Raine, G R Moore, R Hintzen, U Traugot. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis. Laboratory investigation; a journal of technical methods and pathology. vol 59. issue 4. 1988-11-21. PMID:2459499. |
observations from multiple sclerosis lesions showed that oligodendrocyte proliferation and cns remyelination occur in human subcortical white matter, but to a lesser degree than that seen in the cns of mbp/gc/treated guinea pigs. |
1988-11-21 |
2023-08-11 |
human |
| S B Elia. Oligodendrocyte development and the natural history of multiple sclerosis. A new hypothesis for the pathogenesis of the disease. Archives of neurology. vol 44. issue 12. 1987-12-17. PMID:3675264. |
oligodendrocyte development and the natural history of multiple sclerosis. |
1987-12-17 |
2023-08-11 |
Not clear |
| A Suzumura, R P Lisak, D H Silberber. Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: assessment by 51Cr release assay. Journal of neuroimmunology. vol 11. issue 2. 1986-04-16. PMID:3949965. |
in order to quantitate oligodendrocyte cytotoxicity induced by sera from patients with multiple sclerosis (ms) and control sera, we established a 51cr release assay system using cultured oligodendrocytes as target cells. |
1986-04-16 |
2023-08-11 |
Not clear |
| M Hirayama, R P Lisak, D H Silberber. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls. Neurology. vol 36. issue 2. 1986-03-05. PMID:3945400. |
serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls. |
1986-03-05 |
2023-08-11 |
rat |
| C W Adam. Oligodendroglia in multiple sclerosis. Nature. vol 309. issue 5968. 1984-07-17. PMID:6728010. |
oligodendroglia in multiple sclerosis. |
1984-07-17 |
2023-08-12 |
Not clear |
| A Wajgt, M Górn. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta neurologica Scandinavica. vol 68. issue 5. 1984-02-29. PMID:6198864. |
cerebrospinal fluid (csf) from 40 multiple sclerosis (ms) patients was tested by solid-phase radioimmunoassay (ria) for ability to bind 2 common structural components of myelin and oligodendroglia, i.e., to bind myelin basic protein (mbp) and myelin-associated glycoprotein (mag). |
1984-02-29 |
2023-08-12 |
Not clear |
| P F Bartlett, I R Macka. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis. Journal of clinical & laboratory immunology. vol 11. issue 1. 1983-09-09. PMID:6348293. |
multiple sclerosis (ms) is associated with loss of oligodendrocytes within the lesions and the intractability of the disease compared to other demyelinating conditions, both experimental and clinical, suggests, that the oligodendrocyte is the primary target of this disease. |
1983-09-09 |
2023-08-12 |
Not clear |
| S E Poduslo, K Miller, S Zolle. Purification and maintenance in culture of oligodendroglia from human multiple sclerosis brain. Journal of the neurological sciences. vol 54. issue 3. 1982-09-24. PMID:7097309. |
purification and maintenance in culture of oligodendroglia from human multiple sclerosis brain. |
1982-09-24 |
2023-08-12 |
human |
| S E Poduslo, K Miller, S Zolle. Purification and maintenance in culture of oligodendroglia from human multiple sclerosis brain. Journal of the neurological sciences. vol 54. issue 3. 1982-09-24. PMID:7097309. |
oligodendroglia were isolated from human multiple sclerosis (ms) brain obtained at autopsy. |
1982-09-24 |
2023-08-12 |
human |
| B R Mullin, F X Decandis, A J Montanaro, J D Rei. Myelin basic protein interacts with the myelin-specific ganglioside GM4. Brain research. vol 222. issue 1. 1982-01-09. PMID:6170387. |
demyelinated plaques in multiple sclerosis have decreased amounts of both myelin basic protein and sialosylgalactosylceramide (gm4), a ganglioside specifically localized in myelin and oligodendroglia of the central nervous system. |
1982-01-09 |
2023-08-12 |
Not clear |
| U Traugott, S Snyder, C S Rain. Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Annals of neurology. vol 6. issue 1. 1980-01-19. PMID:389147. |
oligodendrocyte staining by multiple sclerosis serum is nonspecific. |
1980-01-19 |
2023-08-11 |
human |
| R P Bunge, M B Bunge, M Cochra. Some factors influencing the proliferation and differentiation of myelin-forming cells. Neurology. vol 28. issue 9 Pt 2. 1979-01-15. PMID:362236. |
fundamental questions arising from study of the multiple sclerosis lesion are: (1) why the myelin-forming oligodendrocyte is adversely affected; and (2) what factors might induce the proliferation and differentiation of replacement oligodendrocytes. |
1979-01-15 |
2023-08-11 |
rat |
| O Abramsky, R P Lisak, D H Silberberg, D Pleasur. Antibodies to oligodendroglia in multiple sclerosis. Transactions of the American Neurological Association. vol 102. 1978-10-27. PMID:616097. |
antibodies to oligodendroglia in multiple sclerosis. |
1978-10-27 |
2023-08-11 |
Not clear |
| O Abramsky, R P Lisak, D H Silberberg, D E Pleasur. Antibodies to oligodendroglia in multiple sclerosis. The New England journal of medicine. vol 298. issue 13. 1978-04-26. PMID:628401. |
antibodies to oligodendroglia in multiple sclerosis. |
1978-04-26 |
2023-08-11 |
Not clear |
| O Abramsky, R P Lisak, D H Silberberg, D E Pleasur. Antibodies to oligodendroglia in patients with multiple sclerosis. The New England journal of medicine. vol 297. issue 22. 1977-12-29. PMID:335246. |
antibodies to oligodendroglia in patients with multiple sclerosis. |
1977-12-29 |
2023-08-11 |
rabbit |
| O Abramsky, R P Lisak, D H Silberberg, D E Pleasur. Antibodies to oligodendroglia in patients with multiple sclerosis. The New England journal of medicine. vol 297. issue 22. 1977-12-29. PMID:335246. |
we demonstrated antibodies to isolated oligodendrocytes and to oligodendroglia in brain sections by indirect immunofluorescence technic in serums of 19 of 21 patients with multiple sclerosis. |
1977-12-29 |
2023-08-11 |
rabbit |
| O Abramsky, R P Lisak, D H Silberberg, D E Pleasur. Antibodies to oligodendroglia in patients with multiple sclerosis. The New England journal of medicine. vol 297. issue 22. 1977-12-29. PMID:335246. |
these findings suggest that antibodies to oligodendroglia are distinct from antibodies to myelin and that demyelination in multiple sclerosis could be a consequence of an immunopathologic reaction directed against oligodendroglial cells. |
1977-12-29 |
2023-08-11 |
rabbit |
| L W Myers, G W Ellison, M E Fewster, F Wolfgra. Cell-mediated immunity to isolated human oligodendroglia in multiple sclerosis. Transactions of the American Neurological Association. vol 100. 1976-08-02. PMID:1226591. |
cell-mediated immunity to isolated human oligodendroglia in multiple sclerosis. |
1976-08-02 |
2023-08-11 |
human |
| M E Fewster, G W Ellison, L W Myers, E Y Kirashig. Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosis. Neurology. vol 25. issue 8. 1975-11-06. PMID:1080263. |
the gliotoxic effect of multiple sclerosis serums and lymphocytes was investigated by the measurement of cr51 release from prelabeled bovine oligodendroglia. |
1975-11-06 |
2023-08-11 |
cattle |
| M E Fewster, G W Ellison, L W Myers, E Y Kirashig. Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosis. Neurology. vol 25. issue 8. 1975-11-06. PMID:1080263. |
there was no difference in glial toxicity between multiple sclerosis patients and normal controls except for a depression of cr51 release from bovine oligodendroglia in the presence of autologous serum plus lymphocytes in the multiple sclerosis patients compared with the normal controls. |
1975-11-06 |
2023-08-11 |
cattle |